Empty Waymo cars are converging on one Atlanta cul-de-sac. No one can explain why
A normally quiet Atlanta neighborhood has suddenly found itself flooded with traffic early in the mo…

Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.
Trend
-58.0% vs SMA 50 · -53.7% vs SMA 200
Momentum
Volume distribution is neutral or leaning toward distribution. No compelling squeeze setup based on current money flow data.
Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.
Analyst consensus estimates · Actuals replace estimates as reported
| Year | Revenue Est. | Rev Gth | EPS Est. | EPS Gth | Range | Analysts |
|---|---|---|---|---|---|---|
FY2023 | $183.4M $177.8M–$189.1M | — | -$0.07 | — | ±4% | Low1 |
FY2024 | $183.3M $177.6M–$189.0M | ▼ -0.1% | $0.13 | — | ±4% | Low1 |
FY2025 | $174.0M $168.6M–$179.4M | ▼ -5.1% | $0.10 | ▼ -19.2% | ±4% | Low1 |
A normally quiet Atlanta neighborhood has suddenly found itself flooded with traffic early in the mo…

Silver Spike Acquisition Corp. (SSAC), an affiliate of Silver Spike Capital, is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The management team and board of directors are composed of veteran cannabis and finance industry executives and founders, including Scott Gordon, founder, and CEO of the Company, who began investing in the cannabis industry in 2014 and in 2016 co-founded and became Chairman of Egg Rock Holdings, the parent company of the Papa & Barkley family of cannabis products with related subsidiary assets in manufacturing, processing and logistics; and Dr. Orrin Devinsky, director of the Company, who is the director of the NYU Langone Comprehensive Epilepsy Center and is a Professor of Neurology, Neuroscience, Psychiatry, and Neuroscience at the NYU School of Medicine and who, since 2016 has served as the Chair of the Medical Advisory Board at Tilray, a pharmaceutical and cannabis company.
| Symbol | Price | Day % | Mkt Cap↓ | P/E | Rev Grw | Margin | ELO |
|---|---|---|---|---|---|---|---|
MAPS◀ | $0.37 | +0.00% | $65M | 27.8 | -531.7% | 112.3% | 1500 |
| $225.32 | -4.42% | $5.5T | 45.6 | +6547.4% | 5560.3% | 1502 | |
| $300.23 | +0.68% | $4.4T | 36.0 | +642.6% | 2691.5% | 1482 | |
| $421.92 | +3.05% | $3.1T | 25.0 | +1493.2% | 3614.6% | 1460 | |
| $425.19 | -3.32% | $2.0T | 80.7 | +2387.4% | 3619.8% | 1500 | |
| $724.66 | -6.62% | $817.2B | 33.8 | +4885.1% | 2284.5% | 1532 | |
| $424.10 | -5.69% | $691.5B | 138.6 | +3433.8% | 1251.5% | 1516 | |
| Sector avg | — | -2.33% | — | 55.4 | +2694.0% | 2733.5% | 1499 |